A new experimental drug is giving hope for people living with advanced multiple sclerosis (MS), particularly those with non-relapsing secondary progressive MS (SPMS), a harsh form of the disease marked by worsening neurological function and increasing disability over time. The results of the study, published in the New England Journal of Medicine, revealed that an […]
